Skip to main content
Log in

Timolol treatment of chronic open-angle glaucoma and ocular hypertension

A 2.5-year multicenter study

  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Maintenance effect of topical timolol was investigated or 2 years in a group of 125 glaucomatous and ocular hypertensive patients (231 eyes) who had been successfully treated with timolol alone during a 6-month period preceding this trial. Intraocular pressure (IOP) was controlled with timolol alone in 135 of 183 eyes (74%) that completed the study. At the end of the trial 142 eyes (78%) showed an IOP of less than 22 mmHg. Other glaucoma medication had to be added to timolol treatment in 18% of ocular hypertensive and 35% of glaucomatous eyes because of IOP elevation. Elevation of IOP seemed to be due to worsening of glaucoma rather than to decreased efficacy of timolol. None of the ocular hypertensive patients developed visual field defects but in ten glaucomatous patients progression of existing visual field defects was observed in association with elevated IOP. Transient adverse effects were observed in 13% of cases, but timolol treatment had to be stopped in only five cases (4%) because of side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Airaksinen PJ (1979) The long-term hypertensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma. Acta Ophthalmol (Copenh) 57:425–434

    Google Scholar 

  • van Buskirk EM (1979) Corneal anesthesia after timolol therapy. Am J Ophthalmol 88: 739–743

    PubMed  Google Scholar 

  • van Buskirk EM (1980) Adverse reactions from timolol maleate administration. Ophthalmology 87:447–450

    PubMed  Google Scholar 

  • Calissendorf BM, Marén N (1980) Timolol-maintenance treatment. Acta Ophthalmol (Copenh) 58:938–946

    Google Scholar 

  • Hass I, Drance SM (1979) Topical timolol in open-angle glaucoma. Can J Ophthalmol 14:235–238

    PubMed  Google Scholar 

  • Kolker AE (1977) Visual prognosis in advanced glaucoma: A comparision of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma. Trans Am Ophthalmol Soc 75:539–555

    PubMed  Google Scholar 

  • Krieglstein GK (1979) Langzeituntersuchungen zur augendrucksenkenden Wirkung von Timolol-Augentropfen. Klin Monatsbl Augenheilkd 175:627–633

    PubMed  Google Scholar 

  • Lin L-L, Galin MA, Obstbaum SA, Katz I (1979) Long-term timolol therapy. Surv Ophthalmol 23:377–380

    Article  PubMed  Google Scholar 

  • McMahon CD, Shaffer RN, Hoskins HD, Hetherington J (1979) Adverse effects experienced by patients taking timolol. Am J Ophthalmol 88:736–738

    PubMed  Google Scholar 

  • Merté HJ, Merkle W (1980) Timolol-Augentropfen in der Glaukombehandlung. Ergebnisse einer Langzeitstudie. Klin Monatsbl Augenheilkd 177:562–571

    PubMed  Google Scholar 

  • Ober M, Scharrer A (1980) Timolol and Adrenalindipivalat bei der Behandlung des erhöhten intraocularen Druckes. Albrecht von Graefes Arch Klin Ophthalmol 213:273–281

    Article  Google Scholar 

  • Olivius E, Thorburn W (1978) Prognosis of glaucoma simplex and glaucoma capsulare. Acta Ophthalmol (Copenh) 56:921–934

    Google Scholar 

  • Oksala A, Salminen L (1980) Zur Tachyphylaxie bei Timololbehandlung des chronischen Glaukoms. Klin Monatsbl Augenheilkd 177:451–454

    PubMed  Google Scholar 

  • Quigley HA, Miller NR, George T (1980) Clinical evaluation of nerve fiber layer atrophy as an indicator of glaucomatous optic nerve damage. Arch Ophthalmol 98:1564–1571

    PubMed  Google Scholar 

  • Radius RL, Diamond GR, Pollack IP, Langham ME (1978) A new drug for management of chronic simple glaucoma. Arch Ophthalmol 96:1003–1008

    PubMed  Google Scholar 

  • Sonntag JR, Brindley GO, Shields MB, Arafat NIT, Phelps CD (1979) Timolol and epinephrine: Comparison of efficacy and side effects. Arch Ophthalmol 97:273–277

    PubMed  Google Scholar 

  • Steinert RF, Thomas JV, Boger III WP (1981) Long-term drift and continued efficacy after multiyear timolol therapy. Arch Ophthalmol 99:100–103

    PubMed  Google Scholar 

  • Strempel I (1979) Timolol: Langzeitergebnisse, Belastungstest und Frühmessungen. Klin Monatsbl Augenheilkd 175:619–626

    PubMed  Google Scholar 

  • Strempel I (1981) Long-term results in the treatment of glaucoma with beta-adrenergic blocking agents. Trans Ophthalmol Soc NZ 33:21–23

    Google Scholar 

  • Takki KK, Klemetti A, Valle O (1982) The IOP-lowering effect of timolol in simple and capsular glaucoma: A multicenter study in Finland. Albrecht von Graefes Arch Klin Ophthalmol 218: 83–87

    Google Scholar 

  • Thomas JV, Epstein DL (1981) Timolol and epinephrine in primary open-angle glaucoma. Arch Ophthalmol 99:91–95

    PubMed  Google Scholar 

  • Urner-Bloch U, Bischoff P (1981) Langzeitbehandlung mit Timolol über drei Jahre. Klin Monatsbl Augenheilkd 179:45–47

    PubMed  Google Scholar 

  • Wilson RP, Spaeth GL, Poryzees E (1980) The place of timolol in the practice of ophthalmology. Ophthalmology 87:451–454

    PubMed  Google Scholar 

  • Öhrström A, Pandolfi M (1980) Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine. Arch Ophthalmol 98:2182–2184

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Airaksinen, P.J., Valle, O., Takki, K.K. et al. Timolol treatment of chronic open-angle glaucoma and ocular hypertension. Graefe's Arch Clin Exp Ophthalmol 219, 68–71 (1982). https://doi.org/10.1007/BF02173443

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02173443

Keywords

Navigation